Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| HIV Antibodies | 7 | 2019 | 776 | 1.62 | Why? |
| Viremia | 7 | 2020 | 1020 | 0.81 | Why? |
| Antibodies, Neutralizing | 13 | 2021 | 25288 | 0.75 | Why? |
| HIV-1 | 7 | 2019 | 3365 | 0.56 | Why? |
| HIV Infections | 8 | 2019 | 11620 | 0.49 | Why? |
| High-Throughput Screening Assays | 1 | 2021 | 1783 | 0.46 | Why? |
| Antibodies, Monoclonal | 6 | 2021 | 8041 | 0.43 | Why? |
| Communicable Diseases | 2 | 2021 | 2148 | 0.39 | Why? |
| Immunization, Passive | 3 | 2018 | 10067 | 0.34 | Why? |
| Antibodies, Viral | 9 | 2021 | 51949 | 0.26 | Why? |
| Disease Models, Animal | 3 | 2018 | 10998 | 0.25 | Why? |
| Eyelids | 1 | 2021 | 40 | 0.22 | Why? |
| Paramyxoviridae Infections | 2 | 2020 | 364 | 0.21 | Why? |
| Virus Latency | 2 | 2018 | 251 | 0.20 | Why? |
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 283 | 0.20 | Why? |
| Immunoglobulin Variable Region | 1 | 2020 | 253 | 0.19 | Why? |
| Proviruses | 1 | 2018 | 82 | 0.18 | Why? |
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 100 | 0.17 | Why? |
| Conjunctiva | 2 | 2021 | 620 | 0.17 | Why? |
| Simian Acquired Immunodeficiency Syndrome | 1 | 2017 | 154 | 0.15 | Why? |
| Germany | 8 | 2021 | 9196 | 0.14 | Why? |
| Pulmonary Aspergillosis | 1 | 2020 | 408 | 0.14 | Why? |
| Simian Immunodeficiency Virus | 1 | 2017 | 251 | 0.14 | Why? |
| CHO Cells | 1 | 2017 | 831 | 0.14 | Why? |
| HIV Envelope Protein gp120 | 1 | 2017 | 267 | 0.14 | Why? |
| Neurons | 1 | 2020 | 864 | 0.13 | Why? |
| Cricetulus | 1 | 2017 | 936 | 0.13 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.13 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2020 | 676 | 0.13 | Why? |
| env Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 386 | 0.13 | Why? |
| Mice | 5 | 2021 | 21357 | 0.12 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 877 | 0.12 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.11 | Why? |
| CD4 Lymphocyte Count | 1 | 2017 | 1517 | 0.11 | Why? |
| Animals | 10 | 2021 | 78931 | 0.11 | Why? |
| RNA-Binding Proteins | 1 | 2018 | 1022 | 0.10 | Why? |
| HIV | 1 | 2017 | 1116 | 0.10 | Why? |
| Nucleic Acid Amplification Techniques | 2 | 2021 | 3388 | 0.10 | Why? |
| Eye Diseases | 1 | 2020 | 1150 | 0.09 | Why? |
| Taste Disorders | 1 | 2020 | 1720 | 0.09 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.09 | Why? |
| Humans | 33 | 2021 | 930598 | 0.09 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 896 | 0.09 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.09 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.09 | Why? |
| Epithelial Cells | 1 | 2021 | 3508 | 0.09 | Why? |
| Sensitivity and Specificity | 4 | 2021 | 22971 | 0.09 | Why? |
| Civil Defense | 1 | 2020 | 1687 | 0.09 | Why? |
| Immunologic Memory | 1 | 2020 | 3362 | 0.09 | Why? |
| Hepatitis C | 1 | 2018 | 1514 | 0.08 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 2426 | 0.08 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2018 | 4545 | 0.08 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.08 | Why? |
| Viral Envelope Proteins | 1 | 2018 | 3539 | 0.08 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.08 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.07 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.07 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 11367 | 0.07 | Why? |
| Viral Load | 4 | 2020 | 15850 | 0.07 | Why? |
| Immunotherapy | 1 | 2018 | 2421 | 0.07 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.07 | Why? |
| Nasopharynx | 2 | 2021 | 10224 | 0.07 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.07 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.06 | Why? |
| Spike Glycoprotein, Coronavirus | 4 | 2021 | 37182 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Brain | 1 | 2020 | 5133 | 0.06 | Why? |
| Clinical Trials as Topic | 2 | 2019 | 7330 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2020 | 3704 | 0.06 | Why? |
| Adult | 10 | 2021 | 244371 | 0.06 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.06 | Why? |
| Male | 13 | 2021 | 367725 | 0.05 | Why? |
| IgG Deficiency | 1 | 2020 | 22 | 0.05 | Why? |
| Anti-HIV Agents | 3 | 2018 | 2209 | 0.05 | Why? |
| Female | 13 | 2021 | 380317 | 0.05 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.05 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Galactose | 1 | 2020 | 201 | 0.05 | Why? |
| tau Proteins | 1 | 2020 | 162 | 0.05 | Why? |
| Enzyme Assays | 1 | 2021 | 295 | 0.05 | Why? |
| Tetraspanin 28 | 1 | 2018 | 38 | 0.05 | Why? |
| Aged | 9 | 2021 | 215776 | 0.05 | Why? |
| Mice, Inbred BALB C | 2 | 2021 | 5814 | 0.05 | Why? |
| Historically Controlled Study | 1 | 2018 | 71 | 0.05 | Why? |
| HIV Envelope Protein gp160 | 1 | 2018 | 33 | 0.05 | Why? |
| Epithelial Cell Adhesion Molecule | 1 | 2018 | 8 | 0.05 | Why? |
| Mannans | 1 | 2020 | 218 | 0.05 | Why? |
| Voriconazole | 1 | 2020 | 206 | 0.05 | Why? |
| Hepatitis C Antibodies | 1 | 2018 | 120 | 0.04 | Why? |
| Hyaluronan Receptors | 1 | 2018 | 61 | 0.04 | Why? |
| Neoplasms, Experimental | 1 | 2018 | 67 | 0.04 | Why? |
| Cell Death | 1 | 2020 | 536 | 0.04 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.04 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.04 | Why? |
| Metapneumovirus | 1 | 2020 | 465 | 0.04 | Why? |
| Binding Sites, Antibody | 1 | 2018 | 466 | 0.04 | Why? |
| Allografts | 1 | 2020 | 761 | 0.04 | Why? |
| Administration, Intranasal | 1 | 2021 | 1132 | 0.04 | Why? |
| Gene Deletion | 1 | 2018 | 430 | 0.04 | Why? |
| Half-Life | 1 | 2017 | 298 | 0.04 | Why? |
| HIV Seropositivity | 1 | 2018 | 320 | 0.04 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 581 | 0.04 | Why? |
| Interleukin-1beta | 1 | 2021 | 992 | 0.04 | Why? |
| Triazoles | 1 | 2020 | 440 | 0.04 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.04 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2018 | 242 | 0.04 | Why? |
| Taste | 1 | 2020 | 715 | 0.04 | Why? |
| Nitriles | 1 | 2020 | 1053 | 0.04 | Why? |
| Inflammasomes | 1 | 2021 | 710 | 0.03 | Why? |
| Glycosylation | 1 | 2018 | 1255 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.03 | Why? |
| Nose | 1 | 2020 | 1093 | 0.03 | Why? |
| Pyridines | 1 | 2020 | 680 | 0.03 | Why? |
| Organoids | 1 | 2020 | 840 | 0.03 | Why? |
| Vero Cells | 2 | 2021 | 14117 | 0.03 | Why? |
| Virus Activation | 1 | 2018 | 480 | 0.03 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 952 | 0.03 | Why? |
| Tertiary Care Centers | 2 | 2021 | 8248 | 0.03 | Why? |
| Receptors, Virus | 2 | 2020 | 5659 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2018 | 1083 | 0.03 | Why? |
| Asymptomatic Infections | 2 | 2021 | 7218 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1014 | 0.03 | Why? |
| Smell | 1 | 2020 | 1851 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.03 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2018 | 2739 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Thorax | 1 | 2020 | 1873 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Phylogeny | 2 | 2018 | 13341 | 0.02 | Why? |
| Antifungal Agents | 1 | 2020 | 1828 | 0.02 | Why? |
| Macrophages | 1 | 2021 | 2784 | 0.02 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Immunoglobulins, Intravenous | 1 | 2020 | 2705 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Hemorrhage | 1 | 2020 | 3013 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.02 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.02 | Why? |
| Child | 3 | 2021 | 70012 | 0.02 | Why? |
| Cough | 1 | 2021 | 4891 | 0.02 | Why? |
| Cross Reactions | 1 | 2018 | 4374 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Macaca mulatta | 1 | 2017 | 3716 | 0.02 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2018 | 9335 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Carrier State | 1 | 2018 | 2100 | 0.02 | Why? |
| Virus Replication | 2 | 2018 | 14331 | 0.02 | Why? |
| Lung Diseases | 1 | 2020 | 2361 | 0.02 | Why? |
| Epitopes | 1 | 2018 | 4113 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Binding Sites | 1 | 2018 | 6201 | 0.02 | Why? |
| Antiviral Agents | 1 | 2018 | 41703 | 0.02 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| HEK293 Cells | 1 | 2018 | 8394 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Fever | 1 | 2021 | 7795 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.02 | Why? |
| Nervous System Diseases | 1 | 2020 | 4092 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Contact Tracing | 1 | 2021 | 8448 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2017 | 5837 | 0.01 | Why? |
| Viral Proteins | 1 | 2018 | 7370 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Viral Vaccines | 1 | 2018 | 7560 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
Klein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(189)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(243)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_